Simultaneous measurement of effective hepatic blood flow and systemic circulation
Related Experiment Video
Updated: Oct 9, 2026

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
Published on: August 4, 2012
1Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Insights
Indocyanine green clearance measures liver function and systemic circulation. In cirrhosis, hyperdynamic circulation may compensate for impaired hepatic function, highlighting the need for simultaneous assessment.
Area of Science:
- Hepatology
- Cardiovascular Physiology
- Clinical Diagnostics
Background:
- Indocyanine green (ICG) disappearance rate reflects both hepatocyte function and hepatic blood flow.
- Systemic circulation significantly influences ICG clearance, a crucial factor in liver function assessment.
- Cirrhotic patients often exhibit a hyperdynamic state despite slower ICG clearance.
Purpose of the Study:
- To simultaneously evaluate hepatic function and systemic circulation in cirrhotic patients.
- To investigate the role of the hyperdynamic state in compensating for impaired liver function.
- To establish the utility of simultaneous ICG clearance measurements for liver function studies.
Main Methods:
- Simultaneous measurement of effective hepatic blood flow and systemic circulation using an indocyanine green clearance meter.
- Quantitative calculation of effective hepatic blood flow based on ICG early disappearance rate, cardiac output, and circulating time.
- Random selection of 46 patients for comprehensive hemodynamic and liver function assessment.
Main Results:
- Quantitative evaluation of hepatic function and hyperdynamic circulation was achieved.
- In normal subjects, ICG disappearance rate correlated with cardiac index.
- Cirrhotic patients displayed reduced ICG clearance despite a relatively high cardiac index, indicating impaired hepatic function masked by hyperdynamic circulation.
Conclusions:
- The indocyanine green clearance meter enables simultaneous assessment of hepatic function and systemic circulation.
- Hyperdynamic circulation appears to be a compensatory mechanism for impaired hepatic function in cirrhotic livers.
- Simultaneous measurement of hepatic and systemic circulation is essential for accurate liver function evaluation.
Background/Aims:
Because the disappearance rate of indocyanine green depends not only on hepatocyte function but also hepatic blood flow, the disappearance rate of indocyanine green is considered to be affected by the systemic circulation. Although the disappearance rate of indocyanine green is slower in cirrhotic patients, a hyperdynamic state is reported to be present. Purpose of this study was to evaluate hepatic function and systemic circulation simultaneously with reference to the hyperdynamic state of cirrhotic liver.
Methodology:
Forty-six patients were selected randomly for this study. Simultaneous measurement of effective hepatic blood flow and systemic circulation using an indocyanine green clearance meter was performed. We calculated the effective hepatic blood flow using the early disappearance rate of indocyanine green movement, cardiac output, and circulating time simultaneously with indocyanine green clearance meter.
Results:
Hepatic function and hyperdynamic circulation could be evaluated quantitatively. The indocyanine green disappearance rate was dependent on cardiac index in normal subjects, whereas the indocyanine green disappearance rate was lower in cirrhotic patients, although the cardiac index was relatively high.
Conclusions:
Hepatic function and systemic circulation could be evaluated simultaneously with this indocyanine green clearance meter. Hyperdynamic circulation was suggested to compensate the impaired hepatic function of cirrhotic liver. Simultaneous measurement of hepatic function and systemic circulation may be essential to studying liver function.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

